Back to Directory Sharon Nachman Email sharon.nachman@stonybrook.edu Institution SUNY Health Science Center at Stony Brook Title Investigator Request an Update Affiliated Studies IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age DAIDS Number 38932 Research Area Therapeutics Study Status Enrolling P1057: Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child DAIDS Number 10270 Research Area Other Study Status Concluded P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded P1061s: Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART. DAIDS Number 10132 Research Area Other Study Status Concluded P1100: AERAS 402 DAIDS Number 11801 Research Area Tuberculosis Study Status Concluded Show All
IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age DAIDS Number 38932 Research Area Therapeutics Study Status Enrolling
P1057: Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child DAIDS Number 10270 Research Area Other Study Status Concluded
P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded
P1061s: Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART. DAIDS Number 10132 Research Area Other Study Status Concluded